eGFR (Creatinine)

Your kidneys quietly clean about 180 liters of fluid every day, and when that filtering slows, almost nothing tells you. There are no symptoms in early kidney disease, and standard creatinine on its own often looks fine well past the point where damage has begun.

eGFR (estimated glomerular filtration rate) is the single number that translates your creatinine into a usable estimate of how well your kidneys are working. Catching the slope of that number early gives you years to act before kidney disease becomes a diagnosis.

What This Number Actually Tells You

eGFR is not a molecule that gets measured. It is a calculation. The lab measures creatinine in your blood (a waste product made by your muscles) and runs it through a formula that includes your age and sex to estimate how many milliliters of plasma your kidneys filter per minute, scaled to a standard body size.

A young, healthy adult typically filters at a rate in the upper end of the population range. After age 30, that rate naturally drifts down by roughly 0.8 to 1.0 mL/min each year. So the number itself is part biology, part arithmetic, and the trend over time tells you more than any single reading.

Why a Low Number Is a Big Deal

As eGFR falls, the risk of serious health problems climbs steeply, and the relationship is not linear. The risk curve is relatively flat at higher filtration levels, then bends sharply upward at lower levels. That bend is why guideline bodies care so much about catching the slide early.

In pooled meta-analyses of general population cohorts, people with lower eGFR were progressively more likely to die from any cause during follow-up compared with people whose eGFR was in the normal range, with hazard ratios rising from roughly 1.2 at moderately reduced filtration to more than 3 at severely reduced filtration. These associations held up after adjusting for age, blood pressure, smoking, cholesterol, diabetes, and prior heart disease.

Kidney Failure

The most direct consequence of declining eGFR is progression toward kidney failure, the point where dialysis or transplant becomes necessary. The largest analysis on this question pooled 27.5 million people from 114 cohorts and found steeply rising risk of needing kidney replacement therapy as filtration fell.

The slope matters as much as the level. In a study of 1.7 million people, a 30% drop in eGFR over two years was strongly linked to future kidney failure, and a 40% drop was even more predictive. Tracking the trajectory of your number is the whole game.

Heart Disease and Cardiovascular Death

Your kidneys and heart share fates more than most people realize. In the Chronic Kidney Disease Prognosis Consortium analyses, the risk gradient between low eGFR and cardiovascular outcomes is actually steeper for heart failure and cardiovascular death than it is for classic heart attack or stroke.

A Mendelian randomization study using UK Biobank data used inherited variants as a natural experiment to test whether lower eGFR actually causes cardiovascular harm rather than just traveling alongside it. Lower genetically predicted eGFR was associated with meaningfully higher cardiovascular mortality. This is one of the strongest available signals that protecting your kidneys protects your heart.

All-Cause Mortality

A community-based study of 95,391 adults in China followed for eight years found that people with severely reduced eGFR were several times more likely to die during follow-up than people with eGFR closer to the normal range. The Rotterdam Study followed about 12,000 adults for nearly a decade and identified four eGFR trajectories. People on the fastest decline path had substantially higher mortality than those whose eGFR stayed stable.

Acute Kidney Injury and CKD Complications

Once eGFR drifts below the normal range, the risk of acute kidney injury rises, as does the chance of complications that follow chronic kidney disease: anemia, weak bones from disturbed calcium and phosphate handling, electrolyte imbalances, and acid buildup. Catching the slide early lets you address these before they cause symptoms.

Why One Reading Is Not Enough

eGFR has built-in biological wobble. The within-person variability is about 5%, and the smallest change you can interpret with confidence (called a reference change value) is roughly 12.5% to 20% from one test to the next. A single reading a few units lower than last time is almost certainly noise.

That is why the value of this test compounds with repetition. Get a baseline, retest in 3 to 6 months if you are making changes or starting a new medication, then at least annually after that. If you have diabetes, high blood pressure, cardiovascular disease, or a family history of kidney disease, push toward two to four times a year. A trend across several readings reveals whether you are on a slow age-related drift or a faster slope that deserves attention.

A change greater than 20% on a follow-up test is beyond what biology alone should produce and warrants a closer look. If you have just started an ACE inhibitor, ARB, or SGLT2 inhibitor, that threshold relaxes, because those medications are known to cause a small early drop that predicts long-term protection.

When Results Can Be Misleading

Several everyday things can move your number without changing your actual kidney function. Knowing them prevents wrong conclusions from a single test.

• A recent meat or fish meal: cooked animal protein raises blood creatinine within two to four hours, which can produce a transient drop in calculated eGFR (the size of the drop depends on how much meat was eaten and how it was cooked, and can be substantial after a large meal). Guidelines recommend at least 12 hours between meat intake and the blood draw.
• Muscle mass extremes: very high muscle mass (bodybuilders, heavy lifters) makes creatinine read high and eGFR look falsely low. Low muscle mass (eating disorders, sarcopenia, paraplegia, amputation) does the opposite and can mask real kidney decline.
• Certain medications shift the number without harming the kidney: trimethoprim, cimetidine, fenofibrate, cobicistat-containing combinations, dolutegravir, and several cancer drugs (tyrosine kinase inhibitors, PARP inhibitors, CDK 4/6 inhibitors) block the small amount of creatinine your kidney tubules normally secrete. The result looks like worse kidney function but reflects a measurement artifact, not actual damage.
• Acute illness, dehydration, or recent surgery: these can transiently raise creatinine through low blood flow to the kidneys or hemoconcentration. eGFR equations assume your kidney function is steady, so they should not be used in the middle of an acute event.

What to Do With an Out-of-Pattern Result

If your eGFR comes back lower than expected, the next move is rarely panic. It is investigation. Pair this number with a urine albumin-to-creatinine ratio (UACR), which detects protein leaking into urine and adds independent information about kidney damage even when eGFR looks fine. The two together form the standard kidney workup, and risk is graded by combining them rather than by eGFR alone.

If your creatinine-based eGFR is borderline or unexpected, ask for a confirmatory cystatin C-based eGFR. Cystatin C is a different blood marker that is not affected by muscle mass, so the two measurements together give a more accurate estimate, especially if you are very muscular, very lean, on chronic steroids, or living with cancer, cirrhosis, or heart failure. When the two estimates disagree meaningfully, the combined equation is more trustworthy.

A sustained drop into the moderately reduced range, especially with any albumin in the urine, is reason to involve a nephrologist or at least have your primary care team run the full CKD evaluation: electrolytes, a complete blood count, urinalysis, and a review of every medication you take through a kidney-function lens. If your eGFR sits in the severely reduced range, or if you lose more than 30% across confirmed readings, nephrology referral is standard.

The Limit of a Single Snapshot

eGFR is one of the most useful numbers you can track, but it is an estimate, and at higher filtration levels it loses precision. At lower levels it becomes very reliable as a risk signal. The combined creatinine-cystatin C equation gets about 90% of estimates within 30% of the true filtration rate, which is the best routine accuracy available outside of a research clinic. Knowing the limits of the tool keeps you from over-reading a small change and from under-reading a real one.